Lexicon Pharmaceuticals, Inc. (LXRX)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 81
- Market Cap
- $1.1B
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
SentiSense also tracks daily options readings for Lexicon Pharmaceuticals, Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Lexicon Pharmaceuticals, Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.